Table 1.
Demographic characteristics
| HIV+ vs. HIV− | HIV+ (n = 146) | HIV− (n = 34) | p value |
|---|---|---|---|
| Age (years) | 31.59 (5.28) | 25.41 (4.45) | <0.001 |
| Education (years) | 10.22 (1.57) | 11.00 (1.63) | 0.010 |
| Sex, % female | 82.19% | 55.88% | 0.001 |
| HIV+: C31S vs. C31C | HIV+ | HIV+ | p value |
| C31S (n = 37) | C31C (n = 109) | ||
| Age (years) | 30.67 (4.95) | 31.91 (5.38) | 0.221 |
| Education (years) | 9.92 (1.48) | 10.32 (1.59) | 0.179 |
| Sex, % female | 78.38% | 83.49% | 0.483 |
| Log10VL | 4.21 (1.00) | 4.17 (1.03) | 0.856 |
| CD4 cell count | 233.1(121.4) | 236.4 (181.5) | 0.920 |
| cART treatment, % yes | 18.35% | 10.8% | 0.285 |
| VL_detectable, % yes | 100% | 97.25% | 0.308 |
| Duration (months) | 13.41(23.49) (n = 32) | 11.76(23.13) (n = 92) | 0.731 |
| CES-D | 5.47(3.65) (n = 32) | 6.19(4.42) (n = 97) | 0.409 |
Age, education, Log10VL, CD4 cell count, duration of infection, and CESD are reported as mean (SD). Note that sample sizes include any individual with at least one of the two types of imaging data types (DTI metrics or brain volumes) available